Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells
H Xu, D Ju, T Jarois, Y Xie - Breast cancer research and treatment, 2008 - Springer
Clinical trials with proteasome inhibitor Bortezomib (also named Velcade or PS-341) has
shown promising results for some cancers. However, other types of cancers including breast …
shown promising results for some cancers. However, other types of cancers including breast …
Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells.
H Xu, D Ju, T Jarois, Y Xie - Breast Cancer Research and …, 2007 - europepmc.org
Clinical trials with proteasome inhibitor Bortezomib (also named Velcade or PS-341) has
shown promising results for some cancers. However, other types of cancers including breast …
shown promising results for some cancers. However, other types of cancers including breast …
[引用][C] Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells
H XU, D JU, T JAROIS, Y XIE - Breast cancer research and …, 2008 - pascal-francis.inist.fr
Diminished feedback regulation of proteasome expression and resistance to proteasome
inhibitors in breast cancer cells CNRS Inist Pascal-Francis CNRS Pascal and Francis …
inhibitors in breast cancer cells CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[引用][C] Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells
H Xu, D Ju, T Jarois, Y Xie - Breast Cancer Research and Treatment, 2007 - cir.nii.ac.jp
Diminished feedback regulation of proteasome expression and resistance to proteasome
inhibitors in breast cancer cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
inhibitors in breast cancer cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells.
H Xu, D Ju, T Jarois, Y Xie - Breast Cancer Research & …, 2008 - search.ebscohost.com
Clinical trials with proteasome inhibitor Bortezomib (also named Velcade or PS-341) has
shown promising results for some cancers. However, other types of cancers including breast …
shown promising results for some cancers. However, other types of cancers including breast …
Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells
H Xu, D Ju, T Jarois, Y Xie - Breast cancer research and …, 2008 - pubmed.ncbi.nlm.nih.gov
Clinical trials with proteasome inhibitor Bortezomib (also named Velcade or PS-341) has
shown promising results for some cancers. However, other types of cancers including breast …
shown promising results for some cancers. However, other types of cancers including breast …
Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells
H Xu, D Ju, T Jarois, Y Xie - Breast Cancer Research and Treatment, 2008 - infona.pl
Clinical trials with proteasome inhibitor Bortezomib (also named Velcade or PS-341) has
shown promising results for some cancers. However, other types of cancers including breast …
shown promising results for some cancers. However, other types of cancers including breast …
Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells
H Xu, D Ju, T Jarois, Y Xie - Breast Cancer Research and …, 2008 - search.proquest.com
Clinical trials with proteasome inhibitor Bortezomib (also named Velcade or PS-341) has
shown promising results for some cancers. However, other types of cancers including breast …
shown promising results for some cancers. However, other types of cancers including breast …